Sorry, but the answer is almost certainly no. We now have good quality data on psylocybin as a treatment for depression; at best, it's slightly more effective than existing treatments, at the cost of a small but significant increased risk side-effects (primarily severe acute anxiety and psychosis, possibly HPPD). We have less data on other psychedelics and other conditions, but none of it looks spectacular when you take into account the usual biases affecting small trials of novel treatments.
Psychedelics are likely to be a good option for some patients, it's good to have another tool in the armamentarium, but the idea that they're a revolution in psychiatry is simply no longer credible.
Psychedelics are likely to be a good option for some patients, it's good to have another tool in the armamentarium, but the idea that they're a revolution in psychiatry is simply no longer credible.
https://pubmed.ncbi.nlm.nih.gov/39627679/
Disclosure: I have participated in a clinical trial of psilocybin for treatment-resistant depression and did not see any meaningful benefit.